GlassScriptPhysician profile
Felipe D Ruiz
NPI 1568605269
$5,656.79
in general payments reported to CMS, 2019-2025
31 companies · $259 in 2025
The $259 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $761 · 2020: $1,180 · 2021: $1,270 · 2022: $639 · 2023: $862 · 2024: $686 · 2025: $259.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,806.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,805.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $2,403.27 | 2019-2025 | Collagenase Santyl, Renasys Touch, Stravix |
| Organogenesis INC. | $634.38 | 2019-2023 | Puraply |
| Tactile Systems Technology INC | $340.31 | 2019-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Koya Medical, INC. | $227.45 | 2024 | Dayspring, Koya Medical |
| Treace Medical Concepts, INC. | $202.57 | 2021 | |
| Alfasigma USA, INC. | $182.89 | 2020-2021 | |
| Sandoz INC. | $177.50 | 2019-2020 | |
| Musculoskeletal Transplant Foundation INC. | $175.65 | 2021-2022 | |
| Horizon Therapeutics Plc | $164.92 | 2019-2021 | |
| Paragon 28, INC. | $137.81 | 2022 | |
| Vaporox, INC. | $117.59 | 2023 | Vht-200 |
| Nevro Corp. | $117.48 | 2021-2023 | Senza |
| Paratek Pharmaceuticals, INC. | $94.53 | 2020-2025 | Nuzyra |
| Bioventus LLC | $84.68 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Abbott Laboratories | $83.33 | 2023-2024 | Proclaim, Eterna, Freestyle Libre 2 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $64.52 | 2019 | |
| Axogen | $57.41 | 2024 | Axoguard Nerve Cap, Axoguard Ha+ Nerve Protector, Axoguard Nerve Protector |
| Melinta Therapeutics, LLC | $54.29 | 2019 | |
| Integra Lifesciences Corporation | $48.24 | 2023-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Stryker Corporation | $40.81 | 2020 | |
| Aroa Biosurgery Incorporated | $38.48 | 2019-2024 | |
| Acera Surgical, INC. | $29.76 | 2019-2025 | Restrata Wound Matrix |
| Amgen INC. | $29.65 | 2024 | Krystexxa |
| Curonix LLC | $28.02 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Averitas Pharma INC. | $27.89 | 2023 | Qutenza |
| Fidia Pharma USA INC. | $18.90 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $18.17 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $16.77 | 2020 | |
| Kci USA, INC. | $15.11 | 2020 | |
| Baudax Bio INC. | $14.85 | 2021 | |
| Polynovo North America LLC | $9.56 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Felipe Ruiz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.